<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Controversy exists regarding the <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E (ApoE) epsilon 4 allele association with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) </plain></SENT>
<SENT sid="1" pm="."><plain>The results range from increased epsilon 4 frequency, similar to that found for <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD), to no association at <z:hpo ids='HP_0000001'>all</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Our objective was to clarify the relationship between ApoE epsilon 4 allele and cerebrovascular disease (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>) in <z:e sem="disease" ids="C0860630" disease_type="Mental or Behavioral Dysfunction" abbrv="">demented</z:e> and cognitively impaired patients </plain></SENT>
<SENT sid="3" pm="."><plain>We examined the ApoE phenotypes in a sample of 452 subjects: 219 with AD, 45 with VaD, 62 with mixed <z:hpo ids='HP_0000726'>dementia</z:hpo> (MD), 45 with mild <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> (MCI) without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e>, 27 in which <z:e sem="disease" ids="C0042373" disease_type="Disease or Syndrome" abbrv="">vascular disease</z:e> was the most probable cause of <z:hpo ids='HP_0001268'>cognitive decline</z:hpo> (vascular mild <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo>, VMCI) and 54 <z:mpath ids='MPATH_458'>normal</z:mpath> controls (NC) </plain></SENT>
<SENT sid="4" pm="."><plain>The study of the epsilon 4 allele frequency showed significant differences between: AD group and the VaD, VMCI and NC groups; MCI group compared with VMCI and NC groups; and MD group versus the VaD and NC groups (p&lt;0.05-0.0001) </plain></SENT>
<SENT sid="5" pm="."><plain>The frequency of the epsilon 4 allele in the VaD and VMCI groups did not differ significantly from NC </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast to other studies, we did not detect a relationship between ApoE epsilon 4 allele and clinically diagnosed VaD </plain></SENT>
<SENT sid="7" pm="."><plain>Our results also show that the epsilon 4 allele is not associated with <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> of vascular origin </plain></SENT>
<SENT sid="8" pm="."><plain>In addition, we have confirmed that the ApoE epsilon 4 allele occurs frequently in <z:hpo ids='HP_0003584'>late-onset</z:hpo> AD and we have found similar association in cognitively impaired individuals without clinical <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CVD</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>These findings should contribute to the assessment of <z:hpo ids='HP_0000726'>dementia</z:hpo> risk profile in the elderly </plain></SENT>
</text></document>